chronic
obstruct
pulmonari
diseas
copd
treatabl
prevent
diseas
state
characteris
progress
airflow
limit
fulli
revers
although
copd
primarili
diseas
lung
appreci
mani
manifest
diseas
outsid
lung
lead
notion
copd
system
diseas
current
diagnosi
copd
reli
larg
descript
measur
enabl
classif
symptom
lung
function
limit
exist
diagnost
strategi
copd
discuss
system
biolog
approach
diagnosi
build
upon
current
molecular
knowledg
diseas
describ
approach
reli
new
labelfre
sens
technolog
highthroughput
surfac
plasmon
reson
spr
also
describ
chronic
obstruct
pulmonari
diseas
copd
treatabl
prevent
condit
characteris
progress
airflow
limit
fulli
revers
copd
associ
abnorm
inflammatori
respons
lung
noxiou
particl
gase
primarili
caus
tobacco
smoke
gather
evid
addit
factor
predispos
patient
copd
genet
suscept
air
pollut
airborn
irrit
may
well
genet
predisposit
also
food
preserv
also
implic
indic
underli
causal
diseas
may
resid
lung
insult
atmospher
copd
project
major
effect
human
health
worldwid
predict
third
frequent
caus
death
copd
consist
three
main
respiratori
patholog
emphysema
respiratori
bronchiol
chronic
bronchiti
separ
distinct
patholog
illustr
heterogen
copd
import
well
defin
copd
phenotyp
although
copd
primarili
diseas
lung
appreci
mani
manifest
diseas
outsid
lung
cachexia
skelet
muscl
dysfunct
cardiovascular
diseas
depress
osteoporosi
lead
concept
copd
system
diseas
diagnosi
copd
base
presenc
typic
symptom
cough
short
breath
togeth
presenc
risk
factor
confirm
spirometri
varieti
method
outlin
figur
use
classifi
sever
diseas
includ
questionnair
gold
bode
index
global
initi
chronic
obstruct
lung
diseas
gold
classifi
copd
four
stage
mild
moder
sever
sever
accord
spirometr
measur
spirometri
howev
believ
correl
poorli
symptom
qualiti
life
exacerb
frequenc
exercis
intoler
recent
comprehens
method
assess
diseas
sever
prognosi
copd
bode
index
multidimension
grade
system
measur
airflow
obstruct
fev
also
incorpor
bodi
mass
index
bmi
dyspnoea
score
exercis
capac
comparison
bode
gold
classif
show
bode
better
predictor
hospitalis
death
gold
conflict
view
preval
copd
rang
major
contribut
factor
may
onethird
physician
know
correct
spirometr
criteria
accord
gold
onethird
train
gp
nurs
trust
spirometr
interpret
skill
addit
main
method
current
use
clinician
classifi
sever
copd
figur
main
method
current
use
clinician
classifi
sever
copd
alli
technic
limit
instrument
use
undertak
spirometr
measur
instrument
variat
signaltonois
ratio
need
consid
although
spirometri
gener
use
measur
airflow
obstruct
number
limit
regard
detect
assess
diseas
spirometri
measur
establish
airflow
obstruct
like
result
long
continu
inflammatori
process
earli
use
therapeut
intervent
howev
may
help
attenu
develop
airway
obstruct
identifi
spirometr
test
singl
fev
measur
give
inform
much
airway
obstruct
alreadi
occur
give
inform
current
level
diseas
activ
present
inform
obtain
serial
measur
assess
reduct
fev
time
final
spirometri
measur
end
result
may
number
diseas
process
known
patient
vari
consider
respons
treatment
exampl
inhal
corticosteroid
possibl
number
pathway
smoke
exposur
lead
final
state
copd
altern
diagnost
approach
may
help
identifi
diseas
subtyp
allow
accur
distinct
copd
chronic
irrevers
asthma
effort
identifi
biomark
copd
sever
group
look
genet
suscept
singl
nucleotid
polymorph
snp
gene
express
protein
express
observ
studi
provid
use
inform
insight
pathogenesi
copd
previous
mention
copd
associ
abnorm
inflammatori
respons
lung
noxiou
particl
gase
due
divers
respons
environment
insult
like
genet
factor
import
within
aetiolog
copd
sever
alpha
defici
proven
genet
risk
factor
copd
date
studi
taken
one
two
approach
either
focus
candid
gene
taken
holist
approach
complet
genomewid
linkag
analysi
studi
identifi
region
genom
confer
suscept
major
consider
genet
studi
howev
larg
size
requir
need
replic
differ
larg
data
set
use
focus
approach
chappel
et
al
identifi
six
haplotyp
gene
increas
risk
diseas
recent
genomewid
linkag
analysi
perform
hersh
et
al
identifi
region
chromosom
show
strong
evid
linkag
lung
function
trait
associ
analysi
identifi
betaglycan
potenti
suscept
gene
copd
support
murin
human
microarray
data
diseasefocus
microarray
studi
howev
lack
consist
identif
copd
gene
express
biomark
exampl
identifi
microarray
studi
gene
overexpress
emphysema
subject
zhang
et
al
subsequ
ning
et
al
use
combin
microarraysag
approach
valid
induct
associ
copd
sever
ning
et
al
went
show
appear
contribut
diseas
pathogenesi
regul
matrixremodel
potenti
fibroblast
proteas
product
bhattacharya
et
al
howev
found
evid
differenti
express
popul
although
studi
one
promis
date
author
present
first
gene
express
biomark
copd
valid
independ
data
set
studi
howev
still
limit
mainli
due
size
sampl
popul
overal
minim
overlap
differenti
express
gene
among
differ
dataset
problem
highlight
complex
express
profil
analysi
human
diseas
copd
tissu
heterogen
variabl
clinic
phenotyp
nonoverlap
gene
dataset
studi
due
sever
factor
includ
differ
sampl
acquisit
diseas
sever
sampl
size
tissu
cell
compon
express
platform
numer
group
look
protein
express
studi
due
technolog
limit
analys
limit
set
protein
shaker
colleagu
examin
six
plasma
protein
known
potenti
interest
copd
enzymelink
immunosorb
assay
elisa
extrem
select
reductionist
approach
abl
show
protein
upregul
downregul
emphasis
need
holist
approach
deliv
molecular
fingerprint
diseas
larger
scale
analysi
protein
copd
undertaken
use
two
differ
techniqu
plymoth
et
al
use
combin
replic
gel
separ
imag
annot
mass
spectrometri
identif
abl
investig
protein
bronchoalveolar
lavag
bal
potenti
identifi
smoker
risk
develop
copd
protein
show
express
pattern
upand
downregul
pintoplata
et
al
went
stage
use
serum
protein
microarray
platform
pmp
provid
data
serum
protein
potenti
interest
highlight
protein
upregul
diseas
acknowledg
author
studi
proof
principl
rather
comprehens
analysi
possibl
biomolecul
relat
copd
despit
intens
research
definit
singl
diseasedefin
biomark
copd
remain
elus
molecul
shown
signific
correl
diseas
statu
often
fail
accur
discrimin
copd
close
relat
diseas
display
similar
symptom
mani
potenti
biomark
suggest
copd
includ
protein
cytokin
antibodi
enzym
inhibitor
also
implic
potenti
target
lung
diseas
gener
system
inflamm
tabl
difficulti
encount
whilst
search
copd
biomark
may
due
part
complex
natur
diseas
compris
broad
spectrum
histopatholog
find
respiratori
symptom
consequ
probabl
find
singl
marker
repres
process
rather
unlik
identif
singl
biomark
also
hinder
high
level
variabl
normal
protein
concentr
amongst
individu
make
difficult
establish
concentr
singl
mediat
indic
diseas
onset
thu
essenti
put
isol
read
context
ie
elev
protein
concentr
indic
presenc
diseas
high
otherwis
normal
read
problem
encount
biomark
identif
uniqu
copd
whilst
focu
biomark
studi
last
decad
primarili
place
use
individu
molecular
biomark
indic
diseas
approach
prove
success
limit
number
diseas
includ
prostat
breast
cancer
measur
prostat
specif
antigen
psa
human
epiderm
growth
factor
receptor
respect
routin
use
diagnost
procedur
new
approach
diseas
diagnosi
gener
therefor
requir
system
biolog
broad
new
paradigm
recent
enter
terminolog
life
biomed
sci
enc
arena
integr
approach
focus
deciph
relationship
interact
gene
protein
cell
element
biolog
system
impact
function
behaviour
system
figur
tradit
omic
field
includ
genom
proteom
metabolom
transcriptom
examin
one
strand
inform
avail
organ
system
biolog
combin
data
field
bioinformat
comput
biolog
engin
principl
examin
organ
system
interconnect
network
network
model
accord
initi
data
obtain
tradit
omic
revis
combin
iter
refin
bootstrap
repeat
random
sampl
taken
dataset
describ
aderem
luca
studi
complex
biolog
system
way
possibl
identifi
emerg
properti
demonstr
individu
omic
field
predict
even
full
understand
part
alon
comprehens
understand
emerg
properti
requir
systemslevel
perspect
obtain
use
simpl
reductionist
approach
studi
start
appli
system
biolog
approach
principl
deciph
pathway
underli
complex
diseas
includ
alzheim
diseas
polyarticular
juvenil
idiopath
arthriti
psychiatr
disord
syndrom
applic
integr
approach
provid
system
biolog
seem
offer
better
rout
understand
diseas
current
understand
system
biolog
reach
point
wherebi
pattern
molecular
behaviour
far
clearer
indic
pathophysiolog
condit
individu
molecular
marker
diseas
possess
uniqu
molecular
fingerprint
could
use
diagnost
differenti
diseas
close
relat
phenotyp
novel
concept
whilst
still
infanc
appli
cancer
diagnosi
ideal
diagnosi
complex
diseas
copd
identif
copdspecif
molecular
fingerprint
sizeabl
problem
due
heterogen
diseas
repres
huge
undertak
differ
diseas
subtyp
would
display
slight
measur
variat
overal
copd
fingerprint
fingerprint
would
also
need
sensit
enough
discrimin
copd
respiratori
diseas
eg
chronic
asthma
mani
display
similar
symptom
initi
copdspecif
molecular
fingerprint
would
compris
biomolecul
alreadi
associ
diseas
rna
protein
molecul
previous
mention
whilst
well
characteris
diseas
target
molecular
speci
may
eventu
form
integr
part
diseasespecif
molecular
fingerprint
target
snp
mirna
posttransl
modif
shown
import
diseas
patholog
thu
diseasespecif
molecular
fingerprint
would
dynam
model
could
adapt
includ
target
new
evid
becom
avail
involv
copd
feasibl
identifi
diseasespecif
biomolecular
pattern
enhanc
recent
advent
proteom
genom
technolog
multiparametr
technolog
includ
beadbas
assay
ie
luminex
cytokin
bead
array
gel
electrophoresi
microarray
platform
dna
protein
mass
spectrometri
provid
opportun
holist
approach
previous
possibl
use
convent
technolog
enzymelink
immunosorb
assay
elisa
implement
highthroughput
technolog
vastli
increas
prospect
biomark
research
facilit
simultan
analysi
multipl
often
ten
thousand
potenti
biomark
minim
sampl
volum
potenti
identifi
novel
target
previous
associ
diseas
interest
vital
extrem
complex
task
identifi
revis
diseasespecif
molecular
fingerprint
system
biolog
begin
piec
togeth
life
scienc
puzzl
employ
system
biolog
approach
routin
diagnost
procedur
howev
would
requir
avail
technolog
allow
simultan
detect
differ
molecular
speci
eg
gene
protein
major
disadvantag
aforement
techniqu
abil
detect
singl
molecular
speci
limit
tradit
proteom
genom
technolog
particularli
elisaand
fluorescencebas
system
would
prohibit
product
system
simultan
detect
multipl
type
biomolecul
difficulti
includ
reagent
limit
need
lengthi
complic
label
incub
detect
procedur
potenti
steric
hindranc
caus
label
bind
site
could
circumv
use
labelfre
technolog
surfac
plasmon
reson
spr
spr
surfac
plasmon
reson
spr
polariton
surfac
electromagnet
wave
propag
direct
parallel
interfac
metal
surfac
extern
medium
eg
liquid
sinc
wave
exist
boundari
metal
extern
liquid
medium
oscil
sensit
chang
boundari
adsorpt
molecul
metal
surfac
phenomenon
enabl
labelfre
realtim
detect
interact
biolog
molecul
metal
surfac
usual
gold
one
frequent
use
configur
technolog
compris
glass
surfac
coat
thin
gold
film
attach
prism
figur
chemic
modif
gold
surfac
allow
attach
ligand
mani
differ
biomolecul
polar
light
laser
light
sourc
interact
gold
surfac
angl
greater
critic
angl
angl
light
coupl
electron
gold
surfac
result
propag
surfac
plasmon
along
surfac
surfac
plasmon
penetr
short
distanc
extern
medium
eg
aqueou
environ
flow
cell
make
highli
sensit
chang
surfac
gold
larg
unaffect
process
bulk
medium
chang
surfac
due
bind
event
readili
monitor
potenti
use
measur
concentr
ligandreceptor
bind
affin
associationdissoci
kinet
potenti
thousand
protein
gene
rapidli
simultan
singl
great
virtu
use
sprbase
detect
modal
labelfre
thu
requir
anyth
identif
apart
select
recognit
appropri
chip
surfac
coupl
appropri
surfac
chemistri
ligand
attach
spr
would
allow
detect
virtual
speci
biomolecul
correct
captur
molecul
select
spr
specif
enough
distinguish
differ
glycosyl
form
antibodi
flexibl
coupl
potenti
increas
sensit
led
upsurg
use
spr
technolog
spr
tradit
use
identif
protein
bind
partner
characteris
bind
event
appli
discoveri
develop
potenti
therapeut
agent
characteris
interact
compound
target
addit
use
characteris
molecul
biochem
interact
process
may
play
role
diseas
patholog
recent
spr
emerg
power
platform
biomark
studi
employ
measur
mani
biomolecul
implic
diseas
tabl
spr
detect
system
deploy
assay
wide
rang
biomolecular
speci
includ
protein
antibodi
snp
sugar
narcot
peptid
small
molecul
microrna
biomark
identifi
within
multipl
type
clinic
sampl
includ
mock
sampl
plasma
serum
saliva
sever
studi
mention
tabl
use
spr
detect
biomark
clinic
relev
concentr
highlight
feasibl
use
spr
clinic
set
exampl
nagel
et
al
abl
differentioutlin
surfac
plasmon
reson
spr
system
utilis
kretschmanraeth
configur
figur
outlin
surfac
plasmon
reson
spr
system
utilis
kretschmanraeth
configur
system
configur
facilit
labelfre
detect
biomolecul
bind
realtim
biomolecul
within
sampl
bind
ligand
immobilis
gold
surfac
caus
chang
level
surfac
plasmon
signal
analysi
chang
enabl
determin
kinet
analyt
concentr
ate
lyme
borreliosi
infect
patient
healthi
donor
spr
analysi
lyme
borreliosi
specif
antibodi
blood
serum
sampl
cho
et
al
use
spr
detect
csfv
antibodi
identifi
pig
infect
classic
swine
fever
vaisocherova
et
al
devis
spr
assay
detect
candid
pancreat
cancer
marker
activ
cell
leukocyt
adhes
molecul
alcam
use
distinguish
alcam
level
cancer
control
sera
measur
made
latter
two
studi
demonstr
compar
specif
sensit
undertaken
classic
detect
techniqu
spr
howev
addit
benefit
labelfre
requir
amplif
step
low
sampl
requir
high
reusabl
requir
sampl
pretreat
advantag
turn
result
decreas
experiment
time
increas
cost
effici
simplif
detect
protocol
allow
lower
user
profici
principl
spr
combin
use
imag
step
spr
imag
spri
allow
gold
surfac
prepar
array
format
provid
opportun
studi
thousand
interact
rapidli
simultan
spri
could
employ
develop
copd
specif
microarray
chip
onto
ligand
biomolecular
compon
copdspecif
molecular
fingerprint
array
figur
diagnost
test
examin
level
biomolecul
within
copd
molecular
fingerprint
would
transform
accuraci
reliabl
reproduc
copd
diagnosi
schemat
represent
demonstr
copdspecif
spr
microarray
chip
could
employ
figur
schemat
represent
demonstr
copdspecif
spr
microarray
chip
could
employ
small
blood
sampl
would
requir
would
separ
serum
cellular
compon
use
microfluid
approach
vari
gene
protein
express
would
monitor
chang
spr
enabl
label
free
detect
assess
discuss
broad
methodolog
chip
design
analyt
implement
offer
much
promis
diseas
detect
manag
initi
copd
specif
microarray
chip
would
array
antibodi
oligonucleotid
antigen
evid
ligand
protein
rna
antibodi
respect
dysregul
copd
whilst
level
complex
biolog
system
vast
incorpor
multipl
cellular
genet
molecular
compon
current
approach
diseasespecif
pattern
analysi
focu
deciph
panel
one
molecular
compon
ie
protein
mrna
comprehens
depict
diseas
state
howev
simultan
examin
mrna
protein
level
molecul
vital
evid
suggest
correl
two
poor
studi
examin
mrna
protein
express
lung
adenocarcinoma
gene
show
signific
correl
correspond
protein
thu
mrna
protein
speci
molecul
examin
even
one
associ
diseas
molecular
fingerprint
copd
refin
repertoir
detect
would
adapt
allow
detect
singl
nucleotid
polymorph
snp
microrna
peptid
enzymessubstr
interact
small
molecul
eg
serotonin
vitamin
histamin
sugar
cell
surfac
marker
appropri
anoth
import
factor
consid
sourc
clinic
sampl
examin
sampl
tradit
examin
case
respiratori
diseas
includ
induc
sputum
bal
lung
tissu
recent
exhal
breath
condens
ebc
sampl
type
could
potenti
analys
pattern
biomark
hinder
invas
cost
high
level
variabl
system
manifest
mani
complex
diseas
includ
copd
make
analysi
bodi
fluid
appeal
option
particular
dynam
natur
blood
mean
reflect
divers
physiolog
patholog
state
individu
coupl
compar
eas
sampl
make
analysi
blood
compon
ultim
target
biomark
applic
utilis
blood
sampl
would
provid
opportun
examin
full
spectrum
molecular
cellular
compon
within
diseasespecif
fingerprint
includ
exclus
solubl
protein
cell
type
cellular
proteinsmark
autoantibodi
posttransl
modif
circul
nucleic
acid
propos
use
whole
blood
sampl
would
requir
step
separ
basi
size
abil
lyse
cell
extract
intracellular
compon
could
achiev
coupl
microfluid
system
previous
describ
chip
allow
insitu
separ
blood
sampl
plasma
cellular
compon
despit
huge
potenti
blood
sampl
diagnost
test
major
challeng
implement
need
overcom
past
investig
plasma
biomark
hinder
fact
plasma
proteom
domin
sever
highli
abund
protein
mask
protein
much
lower
abund
identifi
contribut
diseas
state
trivial
problem
even
case
highli
select
molecularrecognitionbas
protein
identif
technolog
antibodybas
employ
also
import
consid
factor
may
affect
serum
protein
level
includ
psycholog
stress
time
blood
sampl
collect
time
sinc
last
meal
uncontrol
differ
specimen
handl
mani
limit
begin
address
increas
feasibl
comprehens
diagnost
test
plasma
end
preliminari
studi
examin
pattern
biomolecul
includ
protein
autoantibodi
undertaken
success
diseas
graft
versu
host
diseas
chronic
pancreat
brain
cancer
lung
cancer
idiopath
pulmonari
fibrosi
ipf
regard
copd
preliminari
evid
pattern
biomark
peripher
compart
could
use
distinguish
patient
copd
increas
concentr
demonstr
serum
stabl
copd
patient
whilst
studi
consid
proof
principl
rather
comprehens
analysi
possibl
biomolecul
relat
copd
data
provid
evid
system
biolog
approach
copd
diagnosi
evalu
attain
within
blood
addit
whilst
form
complex
network
interact
lung
potenti
copd
biomark
identifi
tabl
detect
within
blood
figur
although
alway
context
copd
molecul
combin
identifi
aforement
studi
could
provid
basi
schemat
represent
key
molecul
associ
copd
lung
peripheri
figur
schemat
represent
key
molecul
associ
copd
lung
peripheri
analysi
molecul
protein
gene
level
would
form
basi
molecular
fingerprint
copd
use
diseas
diagnosi
prototyp
peripher
compart
copd
molecular
fingerprint
addit
develop
hardwar
exquisit
molecular
sensit
key
implement
advanc
detect
modal
includ
analyt
protocol
abl
recognis
complex
biomolecular
pattern
made
differ
molecular
speci
relat
diseas
condit
consider
eg
copd
analyt
model
typic
involv
bayesian
infer
approach
often
start
hidden
markov
model
hmm
essenti
simplest
dynam
bayesian
network
system
studi
assum
markov
process
unknown
paramet
challeng
determin
hidden
ie
diseas
paramet
observ
molecular
data
target
condit
copd
identifi
bayesian
approach
particularli
help
determin
probabl
posit
result
actual
fals
posit
system
biolog
approach
diseas
diagnosi
strive
identifi
presenc
molecular
fingerprint
biomolecul
typic
normal
thu
observ
biomolecular
pattern
suspect
copd
patient
compar
standard
healthi
pattern
diagnos
copd
approach
much
power
diagnosi
base
presenc
alter
concentr
singular
molecular
marker
eg
psa
less
suscept
larg
variat
molecular
marker
concentr
natur
occur
given
popul
holist
measur
biomolecular
pattern
like
reflect
diseas
condit
individu
molecular
marker
therefor
would
augment
detect
process
alon
vision
other
also
adopt
strategi
way
forward
molecular
analysi
alagaratnam
et
al
utilis
bayesian
approach
pursu
muscular
dystrophi
diagnosi
similarli
exampl
use
regard
psa
also
address
use
system
analysi
base
patternmatch
algorithm
group
us
problem
approach
howev
mostli
reli
mass
spectrometri
molecular
measur
expens
requir
signific
invest
operatorskil
less
highthroughput
spr
methodolog
describ
latter
point
extrem
import
commun
screen
employ
similarli
bayesian
approach
way
forward
mine
profil
inform
group
discuss
approach
cover
review
emphasis
pattern
data
import
individu
measur
analyt
approach
exclus
biomed
scienc
pattern
analysi
central
much
imag
analysi
recognit
area
could
well
offer
rich
sourc
analyt
protocol
adopt
sprbase
system
biolog
approach
copd
diagnosi
would
provid
sever
distinct
benefit
potenti
vastli
improv
diseas
diagnosi
classif
evid
describ
earlier
whilst
current
method
copd
diagnosi
ie
spirometri
provid
indic
airway
obstruct
insuffici
accur
diseas
evalu
classif
subtyp
analysi
biomolecular
pattern
would
provid
detail
molecular
cellular
basi
underli
onset
copd
individu
facilit
highli
accur
diseas
diagnosi
classif
would
also
provid
mean
health
copd
patient
could
effici
monitor
inclus
multipl
molecular
speci
within
molecular
fingerprint
provid
far
inform
obtain
analysi
singl
molecular
speci
highlight
stage
express
level
molecul
vari
would
provid
greater
insight
caus
diseas
onset
identifi
import
pathway
examin
help
direct
futur
treatment
strategi
greater
understand
molecular
profil
underli
copd
would
pave
way
person
medicin
drug
treatment
tailor
toward
causal
factor
diseas
individu
earli
symptom
copd
chronic
cough
sputum
product
often
ignor
patient
physician
thought
normal
consequ
smoke
individu
experi
airway
obstruct
spirometr
test
undertaken
time
irrevers
damag
occur
longer
symptom
ignor
wors
declin
lung
function
earli
detect
howev
may
possibl
slow
agerel
declin
lung
function
thu
necessari
find
way
diagnos
copd
stage
treatabl
smoke
cessat
effect
prognosi
sprbase
system
biolog
approach
copd
diagnosi
would
allow
regular
examin
biomolecular
pattern
individu
famili
histori
diseas
expos
diseas
risk
factor
monitor
individu
facilit
signific
improv
earli
diseas
detect
allow
enhanc
drug
intervent
antismok
measur
time
treatment
effect
improv
prospect
life
expect
qualiti
final
benefit
biomolecular
pattern
would
seen
field
drug
discoveri
develop
adopt
strategi
could
use
circumv
problem
associ
phase
iii
clinic
trial
drug
develop
current
assess
therapeut
efficaci
phase
iii
copd
drug
trial
involv
follow
larg
number
patient
long
period
time
order
measur
declin
fev
find
diseas
specif
profil
accur
reflect
current
diseas
activ
would
reduc
need
longterm
expens
clinic
trial
allow
assess
immedi
impact
potenti
drug
therapeut
diseas
mechan
prior
improv
outwardli
detect
symptom
improv
understand
cellular
molecular
basi
copd
pathogenesi
would
also
potenti
provid
new
therapeut
target
current
method
diagnos
copd
reli
spirometri
combin
use
questionnair
arbitrari
measur
diseas
classif
adopt
system
biolog
approach
wherebi
diseas
defin
molecular
fingerprint
analys
would
increas
accuraci
diseas
diagnosi
aid
earlier
diseas
detect
allow
improv
clarif
diseas
subtyp
allow
autom
commun
screen
author
declar
compet
interest
jlr
rau
mainli
wrote
manuscript
well
revis
contribut
equal
studi
lf
conceiv
review
wrote
part
manuscript
po
conceiv
review
edit
wrote
part
manuscript
eaml
jc
rm
help
draft
manuscript
author
read
approv
final
manuscript
